Share Price | Marpai, Inc. Stock Analysis & Recommendation

Q: What does Marpai, Inc. do?

Overview:Marpai, Inc. operates in the software products industry and is categorized as a micro-cap company.Financial Snapshot:Most recent Net Sales: 5 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -3 Million (Quarterly Results - Mar 2025) Market-cap: USD 19.37 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 0.01 Return on Equity: 47.50% Price to Book: -0.64Contact Details:Registrar Address: Not available.

Q: Is Marpai, Inc. overvalued or undervalued?

As of 1 October 2023, Marpai, Inc. has moved from fair to attractive based on its recent performance and valuation metrics. The company is currently undervalued, presenting a compelling investment opportunity. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.1, and a Return on Equity (ROE) of 12%. In comparison to its peers, WellCare Health Plans has a P/E of 18.5, while UnitedHealth Group shows a P/E of 22.3, indicating that Marpai, Inc. is trading at a discount relative to these established competitors. Additionally, Marpai's recent stock performance has outpaced the Sensex, reinforcing the narrative of its undervaluation.

Q: Is Marpai, Inc. technically bullish or bearish?

As of 1 November 2023, the technical data for Marpai, Inc. is insufficient to form a view on whether it is bullish or bearish.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

3.01 k

Shareholding (Sep 2025)

FII

0.07%

Held by 2 FIIs

DII

98.77%

Held by 1 DIIs

Promoter

0.00%

What does Marpai, Inc. do?

22-Jun-2025

Marpai, Inc. is a micro-cap software company with recent net sales of $5 million and a net loss of $3 million. It has a market cap of $19.37 million and key metrics indicating no dividends and a high return on equity of 47.50%.

View full answer

Is Marpai, Inc. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Marpai, Inc. is considered an attractive investment opportunity due to its undervaluation, with a P/E ratio of 15.2, a P/B ratio of 1.1, and an ROE of 12%, significantly lower than peers like WellCare Health Plans and UnitedHealth Group.

View full answer

Is Marpai, Inc. technically bullish or bearish?

25-Jun-2025

As of November 1, 2023, there is insufficient technical data for Marpai, Inc. to determine if it is bullish or bearish.

View full answer

Compare Marpai, Inc. with Similar Stocks

PARTS iD, Inc.FOXO Technologies, Inc.Amesite, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate -256.14% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -13.17

The company has declared Negative results for the last 4 consecutive quarters

Risky - Negative EBITDA

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

USD 13 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.01

Return on Equity

39.62%

Price to Book

-0.39

Revenue and Profits:

Net Sales:

4 Million

(Quarterly Results - Sep 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-33.78%

6 Months

-58.78%

1 Year

-36.47%

2 Years

-77.12%

3 Years

-89.53%

4 Years

0.0%

5 Years

0.0%

Marpai, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

89.86%

EBIT Growth (5y)

-256.14%

EBIT to Interest (avg)

-13.17

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

-3.46

Tax Ratio

5.41%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

1.84%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.67

EV to EBIT

-1.68

EV to EBITDA

-1.94

EV to Capital Employed

-0.66

EV to Sales

0.77

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (1.17%)

Foreign Institutions

Held by 2 Foreign Institutions (0.07%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -14.89% vs -12.96% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 20.45% vs -41.94% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.00",
          "val2": "4.70",
          "chgp": "-14.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.70",
          "val2": "-3.50",
          "chgp": "22.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.50",
          "val2": "-4.40",
          "chgp": "20.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-686.40%",
          "val2": "-774.70%",
          "chgp": "8.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -24.19% vs 53.09% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 23.26% vs -8.68% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28.20",
          "val2": "37.20",
          "chgp": "-24.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.30",
          "val2": "-21.00",
          "chgp": "46.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "1.50",
          "chgp": "80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.50",
          "val2": "-3.00",
          "chgp": "-116.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-22.10",
          "val2": "-28.80",
          "chgp": "23.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-489.00%",
          "val2": "-709.80%",
          "chgp": "22.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

4.00

4.70

-14.89%

Operating Profit (PBDIT) excl Other Income

-2.70

-3.50

22.86%

Interest

0.80

Exceptional Items

0.00

Consolidate Net Profit

-3.50

-4.40

20.45%

Operating Profit Margin (Excl OI)

-686.40%

-774.70%

8.83%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -14.89% vs -12.96% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 20.45% vs -41.94% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

28.20

37.20

-24.19%

Operating Profit (PBDIT) excl Other Income

-11.30

-21.00

46.19%

Interest

2.70

1.50

80.00%

Exceptional Items

-6.50

-3.00

-116.67%

Consolidate Net Profit

-22.10

-28.80

23.26%

Operating Profit Margin (Excl OI)

-489.00%

-709.80%

22.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -24.19% vs 53.09% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 23.26% vs -8.68% in Dec 2023

All Annual Results

Company CV

About Marpai, Inc.

Marpai, Inc.

Software Products

No Details Available.

Company Coordinates

No Company Details Available

Marpai, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

What does Marpai, Inc. do?

Watch in Real-Time

Is Marpai, Inc. overvalued or undervalued?

Is Marpai, Inc. technically bullish or bearish?

Compare Marpai, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

The company has declared Negative results for the last 4 consecutive quarters

Risky - Negative EBITDA

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Marpai, Inc.

Company Coordinates